Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Galpha subunit
BCG1
is essential for pathogenicity of the grey mould fungus Botrytis cinerea. Several processes such as the transition from primary infection to secondary invasive growth and the production of the phytotoxin botrydial are regulated by
BCG1
via a cAMP-independent pathway. Our recent finding that the botrydial biosynthesis genes belong to the group of Ca(2+)/calcineurin-dependent genes suggested for the first time a connection between this Galpha subunit and the calcineurin signalling pathway. To investigate whether this co-regulation of genes by
BCG1
and calcineurin is a common feature, a cDNA macroarray approach was used to compare the gene expression pattern of the wild-type and the Deltabcg1 mutant, non-treated or treated with the calcineurin inhibitor cyclosporin A. We identified three sets of genes whose expression was regulated either by both
BCG1
and calcineurin, or only by one of them. Among the
BCG1
/calcineurin-co-regulated genes, we found a new gene cluster coding for a yet unknown polyketide secondary metabolite. Furthermore, we show for the first time in a phytopathogenic fungus that the
phospholipase C
(BcPLC1) is a component of the
BCG1
- and calcineurin-dependent signalling pathway as several
BCG1
- and calcineurin-dependent genes were downregulated in bcplc1 knock-down mutants.
...
PMID:The Galpha subunit BCG1, the phospholipase C (BcPLC1) and the calcineurin phosphatase co-ordinately regulate gene expression in the grey mould fungus Botrytis cinerea. 1820 91